AGEN
AGENUS INC
Key Financials
Revenue
$114.2M
↑ 10.4%
Operating Income
$-20169000
↑ 83.3%
EPS (Diluted)
$0.00
↑ 100.0%
Net Income
$-37730000
↑ 26.9%
Shareholders' Equity
$-271111000.00
↑ 16.9%
Total Assets
$226.8M
↑ 0.2%
Cash & Equivalents
$3.0M
↓ 92.6%
Operating Cash Flow
$-77195000.00
↑ 51.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 8/13/2026 | View on SEC |
| 4 | 8/12/2026 | View on SEC |
| 8-K | 8/11/2026 | View on SEC |
| 4 | 8/11/2026 | View on SEC |
| 4 | 8/11/2026 | View on SEC |
| 10-Q | 8/7/2026 | View on SEC |
| S-8 | 8/7/2026 | View on SEC |
| S-3 | 8/7/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AGEN |
| Company Name | AGENUS INC |
| CIK | 1098972 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 781-674-4410 |